GlassScriptPhysician profile
Shanda Iona Moore
NPI 1346505302
$1,984.65
in general payments reported to CMS, 2019-2025
18 companies · $131 in 2025
The $131 reported for 2025 was less than what a typical Adult Health (Nurse Practitioner) provider received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $645 · 2022: $372 · 2023: $552 · 2024: $285 · 2025: $131.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $967.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $967.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $567.54 | 2023-2025 | Watchman Flx, Watchman, Watchman Access System |
| Janssen Pharmaceuticals, INC | $301.53 | 2021-2023 | Xarelto |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $271.01 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $171.79 | 2021-2023 | Farxiga |
| Novo Nordisk INC | $138.45 | 2021 | |
| Kestra Medical Technology Services, INC. | $128.41 | 2023 | Assure Wcd |
| Amgen INC. | $88.88 | 2021-2023 | Repatha |
| Merck Sharp & Dohme LLC | $66.69 | 2021-2023 | Verquvo |
| E.R. Squibb & Sons, L.L.C. | $40.96 | 2022-2023 | Camzyos |
| Altathera Pharmaceuticals LLC | $35.40 | 2022-2023 | Sotalol Hydrochloride |
| Braeburn INC. | $31.97 | 2024-2025 | Brixadi |
| Indivior INC. | $29.95 | 2024-2025 | Sublocade |
| Bard Peripheral Vascular, INC. | $28.73 | 2022 | |
| Novartis Pharmaceuticals Corporation | $20.71 | 2023 | |
| Medtronic, INC. | $18.00 | 2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $14.96 | 2021 | |
| Abbvie INC. | $14.87 | 2022 | |
| Lilly USA, LLC | $14.80 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shanda Moore listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.